Gina Giannantoni, PhD, MS, leads ClinMed with 25+ years guiding US and Global Phase I–IV studies in adults/pediatrics across multiple therapeutic areas such as rare diseases, CNS, gene therapy, oncology, urology, immunology, cardiology, and women’s health. She has successfully advanced multiple clinical trial programs in drug/biologics from start-up through execution, overcoming challenges such as unforeseen delays during the pandemic. Dr. Giannantoni has also been recognized with multiple corporate Awards of Excellence and has co-authored several scientific publications.
A seasoned team with expertise in clinical science and operations. We manage early phase as well as large global studies, oversee vendors and labs, ensure regulatory compliance, and drive trials to completion with speed and precision.